Executive Summary
COVID-19 Crisis - Why Now is the Right Time to Invest in Glycemic Management
Get your copy today!
In the midst of the worldwide novel coronavirus pandemic, emerging data suggests that glycemic control for patients with and without a previous diagnosis of diabetes is a critical component for managing the care of critically ill patients.
In this executive summary, you'll learn:
- The striking mortality results of recent COVID-19 research about patient outcomes related to hyperglycemia
- How hyperglycemia in COVID-19 patients impacted length of stay
- Best practices for inpatient glycemic management and what you can do NOW to improve glycemic management for your patients
ECO# 0826-A
